227 related articles for article (PubMed ID: 24814977)
1. Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.
Tripathy S; Lytle KA; Stevens RD; Bain JR; Newgard CB; Greenberg AS; Huang LS; Jump DB
J Lipid Res; 2014 Jul; 55(7):1448-64. PubMed ID: 24814977
[TBL] [Abstract][Full Text] [Related]
2. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
Tripathy S; Jump DB
J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
[TBL] [Abstract][Full Text] [Related]
3. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice.
Fuchs CD; Claudel T; Kumari P; Haemmerle G; Pollheimer MJ; Stojakovic T; Scharnagl H; Halilbasic E; Gumhold J; Silbert D; Koefeler H; Trauner M
Hepatology; 2012 Jul; 56(1):270-80. PubMed ID: 22271167
[TBL] [Abstract][Full Text] [Related]
4. Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.
Tripathy S; Torres-Gonzalez M; Jump DB
J Lipid Res; 2010 Sep; 51(9):2642-54. PubMed ID: 20488798
[TBL] [Abstract][Full Text] [Related]
5. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition.
Wang Y; Torres-Gonzalez M; Tripathy S; Botolin D; Christian B; Jump DB
J Lipid Res; 2008 Jul; 49(7):1538-52. PubMed ID: 18376007
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice.
Fuchs CD; Radun R; Dixon ED; Mlitz V; Timelthaler G; Halilbasic E; Herac M; Jonker JW; Ronda OAHO; Tardelli M; Haemmerle G; Zimmermann R; Scharnagl H; Stojakovic T; Verkade HJ; Trauner M
Hepatology; 2022 Jan; 75(1):125-139. PubMed ID: 34387896
[TBL] [Abstract][Full Text] [Related]
7. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
Qin Y; Dalen KT; Gustafsson JA; Nebb HI
Biochim Biophys Acta; 2009 Feb; 1791(2):140-7. PubMed ID: 19136075
[TBL] [Abstract][Full Text] [Related]
8. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.
Wang Y; Botolin D; Xu J; Christian B; Mitchell E; Jayaprakasam B; Nair MG; Peters JM; Busik JV; Olson LK; Jump DB
J Lipid Res; 2006 Sep; 47(9):2028-41. PubMed ID: 16790840
[TBL] [Abstract][Full Text] [Related]
9. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.
Tanaka N; Takahashi S; Zhang Y; Krausz KW; Smith PB; Patterson AD; Gonzalez FJ
Biochim Biophys Acta; 2015 Jul; 1852(7):1242-52. PubMed ID: 25736301
[TBL] [Abstract][Full Text] [Related]
10. Hepatic ATGL mediates PPAR-α signaling and fatty acid channeling through an L-FABP independent mechanism.
Ong KT; Mashek MT; Davidson NO; Mashek DG
J Lipid Res; 2014 May; 55(5):808-15. PubMed ID: 24610891
[TBL] [Abstract][Full Text] [Related]
11. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice.
Moon YA; Hammer RE; Horton JD
J Lipid Res; 2009 Mar; 50(3):412-423. PubMed ID: 18838740
[TBL] [Abstract][Full Text] [Related]
12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
13. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning.
Ong KT; Mashek MT; Bu SY; Greenberg AS; Mashek DG
Hepatology; 2011 Jan; 53(1):116-26. PubMed ID: 20967758
[TBL] [Abstract][Full Text] [Related]
14. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation.
Schwerbel K; Kamitz A; Krahmer N; Hallahan N; Jähnert M; Gottmann P; Lebek S; Schallschmidt T; Arends D; Schumacher F; Kleuser B; Haltenhof T; Heyd F; Gancheva S; Broman KW; Roden M; Joost HG; Chadt A; Al-Hasani H; Vogel H; Jonas W; Schürmann A
J Hepatol; 2020 Oct; 73(4):771-782. PubMed ID: 32376415
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.
Qin X; Xie X; Fan Y; Tian J; Guan Y; Wang X; Zhu Y; Wang N
Hepatology; 2008 Aug; 48(2):432-41. PubMed ID: 18627005
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism.
Lee MY; Choi R; Kim HM; Cho EJ; Kim BH; Choi YS; Naowaboot J; Lee EY; Yang YC; Shin JY; Shin YG; Chung CH
Exp Mol Med; 2012 Oct; 44(10):578-85. PubMed ID: 22824914
[TBL] [Abstract][Full Text] [Related]
17. GW0742 (PPAR-beta agonist) attenuates hepatic endoplasmic reticulum stress by improving hepatic energy metabolism in high-fat diet fed mice.
Silva-Veiga FM; Rachid TL; de Oliveira L; Graus-Nunes F; Mandarim-de-Lacerda CA; Souza-Mello V
Mol Cell Endocrinol; 2018 Oct; 474():227-237. PubMed ID: 29580823
[TBL] [Abstract][Full Text] [Related]
18. Intracellular pigment epithelium-derived factor contributes to triglyceride degradation.
Dai Z; Zhou T; Li C; Qi W; Mao Y; Lu J; Yao Y; Li L; Zhang T; Hong H; Li S; Cai W; Yang Z; Ma J; Yang X; Gao G
Int J Biochem Cell Biol; 2013 Sep; 45(9):2076-86. PubMed ID: 23886488
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
[TBL] [Abstract][Full Text] [Related]
20. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
